MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$79,996K
EPS
-$1.81
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-06-30
2025-03-31
Total revenue
0
-
Restructuring costs
16,335
-
Research and development expenses
57,275
29,039
General and administrative expenses
10,181
10,982
Total operating expenses
83,791
40,021
Loss from operations
-83,791
-40,021
Other (expense) income, net
-585
-1,342
Interest income
6,382
6,950
Research and development tax credits
752
493
Grant income
183
407
Loss before income taxes
-77,059
-33,513
Income tax expense
1,670
1,100
Net loss
-78,729
-34,613
Foreign currency translation adjustments
-1,217
846
Unrealized gain (loss) on available-for-sale securities
-50
230
Comprehensive loss
-79,996
-33,537
Basic EPS
-1.81
-0.8
Diluted EPS
-1.81
-0.8
Basic Average Shares
43,564,573
43,241,341
Diluted Average Shares
43,564,573
43,241,341
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$79,996K
Net loss
-$78,729K
Foreign currency
translation adjustments
-$1,217K
Unrealized gain (loss) on
available-for-sale securities
-$50K
Loss before income
taxes
-$77,059K
Income tax expense
$1,670K
Interest income
$6,382K
Research and development
tax credits
$752K
Grant income
$183K
Loss from operations
-$83,791K
Other (expense)
income, net
-$585K
Total operating
expenses
$83,791K
Research and development
expenses
$57,275K
Restructuring costs
$16,335K
General and
administrative expenses
$10,181K
Buy us a coffee
iTeos Therapeutics, Inc. (ITOS)
iTeos Therapeutics, Inc. (ITOS)